A wide variety of therapeutic modalities are now available as biological drugs such as antibodies, virus vectors, nucleotides, peptides and extracellular vesicles. It is important to develop a proper downstream process for a specific biological drug. This symposium aims to understand the current situation and discuss on the future direction.